Day: January 22, 2026

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) — U.S. investors and the market continue to reframe environmental, social and governance (ESG) policies and initiatives to focus on sustainable and responsible business practices that drive business value creation. As a result, companies have refined their approach to executive incentive plans by establishing quality metrics that are aligned with stewardship of shareholder value, especially with a focus on human capital, according to a new global study by WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company. The annual study also revealed the prevalence of metrics related to diversity, equity and inclusion (DEI) declined in light of recent Court rulings and Executive Orders, yet human capital remains the most prevalent non-financial metric category in executive incentive...

The transactions represent an issuance of up to 2.25 million shares of SATA in the aggregate DALLAS, Jan. 22, 2026 (GLOBE NEWSWIRE) — Strive, Inc. (Nasdaq: SATA) (“Strive” or the “Company”) today announced the pricing of its follow-on offering (the “offering”) on January 22, 2026 of 1,320,000 shares of Strive’s Variable Rate Series A Perpetual Preferred Stock (the “SATA Stock”), an upsize over the $150 million transaction size previously announced when taken together with the anticipated privately negotiated notes exchanges, at an offering price of $90 per share. Strive intends to use the net proceeds of this offering, together with cash on hand and potentially cash from terminating Strive’s existing capped call transactions relating to the outstanding 4.25% Convertible Senior Notes due 2030 (the “Semler Convertible Notes”) issued...

HighlightsAmerican Rare Earths in partnership with the University of Wyoming has been selected for a research award to examine and explore end-uses for the tailings and other byproducts resulting from rare earth elements production at Halleck Creek. Determining viable end-uses for byproducts may potentially enhance Halleck Creek’s economics and reduce the project’s overall footprint.DENVER, Jan. 22, 2026 (GLOBE NEWSWIRE) — American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”), through its fully owned subsidiary Wyoming Rare (USA) Inc., in partnership with the University of Wyoming (“UW”) School of Energy Resources (“SER”) has been selected for a Seed Translational Acceleration of Research (“STAR”) Project award. This competitive funding, provided through UW’s National Science Foundation (“NSF”)...

Company to Begin Trading Under New Symbol “EZRA” on January 26, 2026 Acquisition Strategy Offers Transformative Potential, Complementing Cash Flow Foundation of Insurance Holdings LAKEWOOD, NJ, Jan. 22, 2026 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (the “Company”) today announced that its ticker symbol on the NASDAQ Capital Market will change from “RELI” to “EZRA”, effective at the open of trading on Monday, January 26, 2026. The Company’s common stock will continue to be listed on NASDAQ, and its CUSIP number will remain unchanged. The ticker symbol change is intended to better reflect the Company’s strategic evolution, including the formation of EZRA International Group, a new division focused on acquiring controlling stakes and accelerating the growth of breakthrough technology companies, with an initial...

New physically backed ETF brings regulated Dogecoin exposure to U.S. investors NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) — 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced the launch of the 21shares Dogecoin ETF (Ticker: TDOG). 21shares is the only ETF provider endorsed by the House of Doge1. TDOG offers investors direct exposure to Dogecoin (DOGE) through a fully backed, transparent, and exchange-traded vehicle. The new ETF will begin trading on NASDAQ on 22 January 2026. TDOG provides investors with secure and straightforward access to DOGE, holding the asset on a 1:1 basis in institutional-grade custody. TDOG allows investors to participate in Dogecoin’s growth without navigating digital wallets, crypto exchanges, or custody complexities – using the same brokerage accounts they...

New physically backed ETF brings regulated Dogecoin exposure to U.S. investors NEW YORK and MIAMI, Jan. 22, 2026 (GLOBE NEWSWIRE) — House of Doge, the official corporate arm of the Dogecoin Foundation, along with merger partner Brag House Holdings Inc. (NASDAQ: TBH), today announced the launch of the 21shares Dogecoin ETF (Ticker: TDOG) (the “Fund”), the only Dogecoin ETF provider endorsed by the Dogecoin Foundation1. Launched by House of Doge partner 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), TDOG offers investors direct exposure to Dogecoin (DOGE) through a fully backed, transparent, and exchange-traded vehicle. The new ETF will begin trading on NASDAQ on 22 January 2026. The 21shares Dogecoin ETF (TDOG) provides investors with secure and straightforward access to DOGE, holding the asset...

GETTYSBURG, Pa., Jan. 22, 2026 (GLOBE NEWSWIRE) — ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc., announced net income of $10.8 million, or $1.04 diluted earnings per share, for the three months ended December 31, 2025 compared to net income of $6.6 million, or $0.77 diluted earnings per share, for the three months ended December 31, 2024 and compared to net income of $14.9 million, or $1.42 diluted earnings per share, for the three months ended September 30, 2025. Core net income1 was $14.0 million for the three months ended December 31, 2025 compared to core net income1 of $7.3 million for three months ended December 31, 2024 and core net income1 of $15.0 million for the three months ended September 30, 2025. The Corporation reported net...

Executed in accordance with FDA human factors and usability engineering guidance, the study is intended to de-risk downstream regulatory review and support a streamlined path toward clinical development Raanana, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced the initiation of a key usability (Human Factors) study program for its lead product candidate, NASARIX™, an innovative intranasal allergy blocker designed for broad consumer use. The study marks an important value-inflection milestone in Polyrizon’s development roadmap and is being conducted to confirm alignment with U.S. Food and Drug Administration (FDA) requirements for critical product elements, including...